Teva Pharmaceutical Industries reported $1.01B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Guangzhou Baiy CNY 1.93B 83.5M Sep/2026
Jiangsu Hengrui CNY 2.93B 143.13M Sep/2026
Kalbe Farma IDR 676.58B 838.43B Sep/2026
Richter Gedeon HUF 57.76B 2.43B Jun/2026
Sh Fosun Pharma CNY 3.07B 276.55M Sep/2026
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.01B 27M Sep/2026